Michael Robo, PhD, is a computational chemist with experience in free energy calculations, molecular docking and molecular mechanics. His primary responsibilities are to use computational tools to prioritize compounds for synthesis and/or experimental assay in the high-throughput screening, hit to lead and lead optimization stages of drug development.
Robo has investigated a diverse array of topics, including organometallic systems, force-enabled chemistry and protein-ligand systems. Prior to joining the IBRI, he was a postdoctoral researcher in the Vilseck Lab at the Indiana University School of Medicine, where he developed new methods of free energy calculation.